X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3635) 3635
Publication (298) 298
Newsletter (239) 239
Book Review (78) 78
Conference Proceeding (64) 64
Newspaper Article (41) 41
Book Chapter (12) 12
Magazine Article (7) 7
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abatacept (3584) 3584
humans (2097) 2097
animals (1485) 1485
ctla-4 antigen (1398) 1398
immunoconjugates (1375) 1375
index medicus (1148) 1148
antigens, cd (1139) 1139
immunology (1077) 1077
mice (995) 995
female (991) 991
male (924) 924
rheumatoid arthritis (815) 815
rheumatology (712) 712
t-lymphocytes - immunology (586) 586
immunoconjugates - therapeutic use (584) 584
arthritis, rheumatoid - drug therapy (563) 563
antirheumatic agents - therapeutic use (527) 527
transplantation (526) 526
middle aged (520) 520
adult (474) 474
immunosuppressive agents - therapeutic use (436) 436
treatment outcome (425) 425
ctla-4 (421) 421
antigens, differentiation - genetics (410) 410
lymphocyte activation (404) 404
rheumatoid factor (403) 403
antigens, differentiation - immunology (395) 395
arthritis (393) 393
t cells (372) 372
surgery (358) 358
expression (355) 355
cd28 (354) 354
mice, inbred c57bl (352) 352
double-blind (346) 346
rituximab (342) 342
activation (332) 332
mice, inbred balb c (318) 318
research (302) 302
aged (301) 301
care and treatment (288) 288
methotrexate (287) 287
costimulation (283) 283
immunosuppressive agents - pharmacology (272) 272
cd28 antigens - immunology (268) 268
rats (267) 267
antigens, differentiation - metabolism (264) 264
in-vivo (264) 264
abatacept - therapeutic use (256) 256
antibodies, monoclonal - therapeutic use (251) 251
analysis (243) 243
b7-2 antigen (235) 235
induction (230) 230
rheumatoid-arthritis (230) 230
medicine, research & experimental (227) 227
drug therapy (222) 222
tumor necrosis factor-alpha - antagonists & inhibitors (221) 221
antigens, differentiation - physiology (220) 220
cells, cultured (217) 217
b7-1 antigen - immunology (212) 212
graft rejection - prevention & control (212) 212
lymphocytes (212) 212
disease (211) 211
time factors (210) 210
infliximab (206) 206
antirheumatic agents - adverse effects (205) 205
therapy (204) 204
cd4-positive t-lymphocytes - immunology (203) 203
immunoconjugates - pharmacology (203) 203
tolerance (198) 198
immunosuppression (193) 193
efficacy (190) 190
immunoconjugates - adverse effects (189) 189
safety (189) 189
tocilizumab (189) 189
adalimumab (184) 184
receptor (183) 183
etanercept (182) 182
transplantation, homologous (179) 179
antigen (174) 174
molecular sequence data (174) 174
graft rejection - immunology (172) 172
arthritis, rheumatoid - immunology (171) 171
pharmacology & pharmacy (171) 171
cd28 antigens - metabolism (169) 169
dendritic cells (169) 169
antigens, differentiation - pharmacology (168) 168
immunotherapy (167) 167
monoclonal-antibody (165) 165
drug therapy, combination (164) 164
t-cell activation (164) 164
t-cells (161) 161
b7-1 antigen - metabolism (156) 156
health aspects (154) 154
kidney transplantation (154) 154
lymphocyte activation - immunology (154) 154
rats, inbred lew (153) 153
antirheumatic agents (151) 151
inadequate response (150) 150
t-lymphocytes - drug effects (149) 149
risk factors (148) 148
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3706) 3706
Japanese (54) 54
German (48) 48
French (45) 45
Spanish (29) 29
Chinese (26) 26
Russian (9) 9
Czech (6) 6
Hungarian (6) 6
Portuguese (6) 6
Italian (5) 5
Polish (5) 5
Danish (3) 3
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Revue du rhumatisme, ISSN 1169-8330, 11/2016, Volume 83, p. A98-A99
Journal Article
Drugs, ISSN 0012-6667, 7/2017, Volume 77, Issue 11, pp. 1221 - 1233
The biological DMARD (bDMARD) abatacept (Orencia®), a recombinant fusion protein, selectively modulates a co-stimulatory signal necessary for T-cell... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | SUBCUTANEOUS ABATACEPT | RADIOGRAPHIC PROGRESSION | CO-STIMULATION MODULATOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PHASE IIIB | PHARMACOLOGY & PHARMACY | INTRAVENOUS ABATACEPT | TOXICOLOGY | METHOTREXATE-NAIVE PATIENTS | HEAD-TO-HEAD | DAMAGE PROGRESSION | Abatacept - pharmacology | Antirheumatic Agents - administration & dosage | Humans | Treatment Outcome | Clinical Trials as Topic | Methotrexate - therapeutic use | Methotrexate - adverse effects | Abatacept - adverse effects | Immunoconjugates - pharmacology | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Immunoconjugates - therapeutic use | Adult | Antirheumatic Agents - pharmacokinetics | Methotrexate - administration & dosage | Drug Therapy, Combination | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Care and treatment | Usage | Dosage and administration | Abatacept | Drug therapy | Rheumatoid arthritis | Intravenous administration | Pathogenesis | Clinical trials | Systematic review | Lymphocytes T | Arthritis | Proteins | Cell activation | Lymphocytes | Remission | Methotrexate | Fusion protein | Recombinant | Antigens | Signs and symptoms | Biological products | Rheumatology | T cell receptors | Patients | Immunogenicity | Tumor necrosis factor | Structural damage | TNF inhibitors | Cost analysis | Health risk assessment
Journal Article
U.S. Pharmacist, ISSN 0148-4818, 10/2011, Volume 36, Issue 10, pp. 60 - 68
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 01/2013, Volume 80, Issue 1, p. 46
Evaluer l'efficacite de l'abatacept chez les patients ayant une spondylarthropathie (SpA) axiale refractaire au traitement par anti-TNF-[alpha]. 
Abatacept
Journal Article
Zeitschrift fur Rheumatologie, ISSN 0340-1855, 07/2009, Volume 68, Issue 5, p. 380
Der klinische Erfolg der Depletierung von B-Zellen durch den Anti-CD20-Antikorper Rituximab hat eine neue Ara in der Therapie rheumatischer Erkrankungen... 
Abatacept
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 09/2018, Volume 70
Conference Proceeding
BMC Musculoskeletal Disorders, ISSN 1471-2474, 05/2016, Volume 17, Issue 1, p. 231
Journal Article
Journal Article
ANNALS OF THE RHEUMATIC DISEASES, ISSN 0003-4967, 06/2017, Volume 76, pp. 816 - 816
Conference Proceeding
Arthritis Research and Therapy, ISSN 1478-6354, 05/2017, Volume 19, Issue 1, pp. 97 - 11
Journal Article
Journal Article
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 07/2019, Volume 86, Issue 4, p. 326
Resume L'obesite est une epidemie mondiale dont un nombre croissant d'elements probants suggere une influence sur la reponse de l'organisme aux traitements... 
Psoriasis | Abatacept | Lymphocytes
Journal Article
P and T, ISSN 1052-1372, 03/2006, Volume 31, Issue 3, pp. 149 - 153
Journal Article
BMC Pharmacology and Toxicology, ISSN 2050-6511, 04/2016, Volume 17, Issue 1, pp. 17 - 17
Background: Abatacept (ABA) is a fusion receptor protein containing the CTLA-4 domain that prevents the activation of naive T cells by binding the CD80 and... 
Reactivation | Abatacept | Rheumatoid arthritis | Hepatitis B | RHEUMATOID-ARTHRITIS | RECOMMENDATIONS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Hepatitis B Antibodies - analysis | Hepatitis B, Chronic - immunology | Antirheumatic Agents - administration & dosage | Arthritis, Rheumatoid - blood | Humans | Male | Methotrexate - therapeutic use | Arthritis, Rheumatoid - complications | Abatacept - administration & dosage | Asymptomatic Infections | Drug Therapy, Combination - adverse effects | Arthritis, Rheumatoid - drug therapy | Lamivudine - therapeutic use | Antirheumatic Agents - adverse effects | Hepatitis B virus - immunology | Antirheumatic Agents - therapeutic use | Antiviral Agents - therapeutic use | Treatment Outcome | Biomarkers - blood | Hepatitis B virus - physiology | Arthritis, Rheumatoid - virology | DNA, Viral - blood | Hepatitis B, Chronic - virology | Hepatitis B virus - drug effects | Abatacept - adverse effects | Hepatitis B, Chronic - complications | Hepatitis B, Chronic - drug therapy | Virus Activation - drug effects | Abatacept - therapeutic use | Aged | Hepatitis B virus - isolation & purification | Infusions, Intravenous | Drug Monitoring | Corticosteroids | Dendritic cells | Immunoglobulin G | Liver | Lamivudine | Arthritis | Prednisone | T cells | Infection | Rheumatoid factor | Methotrexate | Drug therapy | Health aspects | Index Medicus
Journal Article